World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
20156
World Ranking
18820
National Ranking
629

Lionel Galicier publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lionel Galicier sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 363 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lionel Galicier D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lionel Galicier sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 76 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lionel Galicier is affiliated with the Université Paris Cité in France, contributing extensively to the field of Medicine with a focus on hematology and related disciplines. Their body of work spans over 200 publications, emphasizing several subfields including Hematology, Immunology, Oncology, Genetics, and Epidemiology.

The scientist's research topics include:

  • Platelet Disorders and Treatments
  • Viral-associated cancers and disorders
  • Complement system in diseases
  • Cytomegalovirus and herpesvirus research
  • Blood groups and transfusion
  • Immunodeficiency and Autoimmune Disorders
  • Parvovirus B19 Infection Studies

Among Lionel Galicier's notable recent papers are:

  • "Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study" (2022) published in Blood
  • "A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP" (2020) published in Blood
  • "Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series" (2020) published in British Journal of Haematology
  • "Complement C5 inhibition in patients with COVID-19 - a promising target?" (2020) published in Haematologica
  • "Management of HIV-infected patients in the intensive care unit" (2020) published in Intensive Care Medicine

Frequent coauthors collaborating with Lionel Galicier include:

  • David Boutboul
  • Éric Oksenhendler
  • Marion Malphettes
  • Paul Coppo
  • Élie Azoulay

The scientist has published prominently in several journals and venues, notably:

  • Blood (13 publications)
  • La Revue de Médecine Interne (13 publications)
  • British Journal of Haematology (7 publications)
  • Blood Advances (6 publications)
  • American Journal of Hematology (5 publications)

Lionel Galicier's accumulated work largely concentrates on clinical and translational research at the intersection of immune regulation, blood disorders, and infectious complications. They have contributed to understanding therapeutic strategies in complex hematological conditions including thrombocytopenia, immune-mediated thrombotic microangiopathies, and the role of complement inhibition in disease processes.

Best Publications

  • Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.

    Laurence Fardet;Lionel Galicier;Olivier Lambotte;Christophe Marzac

  • XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome

    Stéphanie Rigaud;Marie-Claude Fondanèche;Nathalie Lambert;Nathalie Lambert;Benoit Pasquier

  • Infections in 252 patients with common variable immunodeficiency.

    Eric Oksenhendler;Laurence Gérard;Claire Fieschi;Marion Malphettes

  • High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

    Eric Oksenhendler;Emmanuelle Boulanger;Lionel Galicier;Ming-Qing Du

  • Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

    B. Piqueras;C. Lavenu-Bombled;L. Galicier;F.Bergeron-Van Der Cruyssen

  • Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP-deficiency) versus type 2 (XLP-2/XIAP-deficiency)

    Jana Pachlopnik Schmid;Jana Pachlopnik Schmid;Danielle Canioni;Despina Moshous;Despina Moshous;Fabien Touzot

  • Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience

    Paul Coppo;Michael Schwarzinger;Marc Buffet;Alain Wynckel

  • Reactive Hemophagocytic Syndrome in Adults: A Retrospective Analysis of 162 Patients

    Sébastien Rivière;Lionel Galicier;Paul Coppo;Christophe Marzac

  • Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

    Bertrand Godeau;Raphael Porcher;Olivier Fain;François Lefrère

  • Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center

    Antoine Froissart;Marc Buffet;Agnès Veyradier;Pascale Poullin

  • Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy

    Eric Mariotte;Elie Azoulay;Lionel Galicier;Eric Rondeau

  • Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study

    Elodie Elkaim;Elodie Elkaim;Benedicte Neven;Benedicte Neven;Benedicte Neven;Julie Bruneau;Julie Bruneau;Kanako Mitsui-Sekinaka

  • Microbial ecology perturbation in human IgA deficiency

    Jehane Fadlallah;Hela El Kafsi;Delphine Sterlin;Catherine Juste

  • Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.

    Laurence Gérard;Alice Bérezné;Lionel Galicier;Véronique Meignin

  • Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura.

    Marie Moatti-Cohen;Céline Garrec;Martine Wolf;Pierre Boisseau

  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

    Pierre-Louis Tharaux;Gilles Pialoux;Arthur Pavot;Xavier Mariette

  • Severe ADAMTS13 Deficiency in Adult Idiopathic Thrombotic Microangiopathies Defines a Subset of Patients Characterized by Various Autoimmune Manifestations, Lower Platelet Count, and Mild Renal Involvement

    Paul Coppo;Djaouida Bengoufa;Agnès Veyradier;Martine Wolf

  • Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature.

    Marc Michel;Valérie Chanet;Lionel Galicier;Marc Ruivard

  • Understanding organ dysfunction in hemophagocytic lymphohistiocytosis.

    Caroline Créput;Lionel Galicier;Sophie Buyse;Elie Azoulay

  • Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy.

    Michael Darmon;Guillaume Thiery;Magali Ciroldi;Sandra de Miranda

Frequent Co-Authors

Eric Oksenhendler
Eric Oksenhendler Université Paris Cité
Elie Azoulay
Elie Azoulay Université Paris Cité
Claire Fieschi
Claire Fieschi Université Paris Cité
Olivier Fain
Olivier Fain Université Paris Cité
Olivier Lambotte
Olivier Lambotte University of Paris-Saclay
Michael Darmon
Michael Darmon Université Paris Cité
Olivier Hermine
Olivier Hermine Necker-Enfants Malades Hospital
Capucine Picard
Capucine Picard Université Paris Cité
Alain Fischer
Alain Fischer Collège de France
Zahir Amoura
Zahir Amoura Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to a range of rewarding healthcare careers. Beyond earning a traditional MD, many students explore related online degrees that offer flexibility and specialized knowledge. For example, pharmd online programs prepare graduates for advanced pharmacy roles and leadership in pharmaceutical care.

Those interested in healthcare management may consider an online mhi (Master of Health Information) to excel in managing patient data and healthcare technology. Alternatively, entry-level opportunities abound for those who complete cheapest medical billing and coding online courses, which can lead to vital administrative roles in hospitals and clinics.

If you are focused on clinical practice and direct patient care, the most affordable online nurse practitioner programs enable nurses to advance their credentials and responsibilities. Ultimately, these online pathways can complement or enhance your medical education, preparing you for a diverse range of careers within the healthcare sector.

Best Scientists Citing Lionel Galicier

Trending Scientists

Recently Published Articles